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Physical activity is a cornerstone of secondary prevention after acute coronary syndromes 
(ACS). Guidelines strongly recommend that post-ACS patients achieve ≥30 minutes of 
moderate aerobic activity such as brisk walking on at least 5 days per week within 2 weeks 
of discharge (1). Yet, little is known about the extent to which post-ACS patients are meeting 
physical activity guidelines. Prior studies assessing physical activity after ACS were limited 
by reliance on self-reports (2). The purpose of this study was to use an objective measure of 
physical activity to describe the proportion of ACS patients following physical activity 
recommendations in the high-risk post-discharge period.
Between 2009 and 2012, we enrolled patients hospitalized for myocardial infarction (MI) or 
unstable angina (UA) into the Prescription Use, Lifestyle, and Stress Evaluation (PULSE) 
study. Some patients participated in an ancillary study in which they were provided with an 
Actical accelerometer (Philips Respironics, Bend, Oregon) at or soon after discharge (3). 
Patients were asked to continuously wear the device on their non-dominant wrist and to 
return the device one month later. All patients provided informed consent. The institutional 
review board of Columbia University Medical Center approved the study.
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The accelerometer is a validated wristwatch-like, omni-directional accelerometer that 
provides ambulatory monitoring and quantification of activity levels. It records data in 1-
minute epochs, and provides activity counts for each minute of the day that are classifiable 
by intensity level. For the current analyses, patients were required to have worn the device 
for ≥10 hours on ≥3 days in 1 week during the 35 days after discharge. Consistent with 
guidelines, patients were categorized into three levels of physical activity based on percent 
of valid wear days with ≥30 minutes of moderate-to-vigorous physical activity (MVPA) bout 
minutes [none; insufficient (1%–65% of days); met guidelines (≥66% of days) (4). The 
probability that patients met the guidelines each week was estimated using logistic 
regression with generalized estimating equations accounting for within-subject correlation 
and adjusting for covariates that influence physical activity [age, sex, ethnicity, race, partner 
status, GRACE score, Charlson comorbidity index, depression (Beck Depression Inventory 
score ≥10), decreased left ventricular ejection fraction (LVEF<40%), body mass index, 
regular exercise before ACS, ACS type (unstable angina, non-ST elevation MI, or ST 
elevation MI), and ACS treatment (medical management, percutaneous coronary 
intervention, or coronary artery bypass graft)]. Analyses were conducted using R version 
3.2.4 (R Foundation for Statistical Computing, Vienna, Austria).
Of 620 patients provided with accelerometers, 330 (52.9%) returned devices with sufficient 
data. The mean age of patients was 62.9 ± 10.9 years, 31.2% were women, 38.7% were 
Hispanic, 20.1% were black, 14.7% had decreased LVEF, and 34.5% were depressed. There 
were no differences in demographic or comorbidity characteristics between those who did 
and did not return accelerometers with sufficient data. An increasing proportion of patients 
met the physical activity guidelines over time (P<0.001; Figure). Nevertheless, by the fifth 
week after discharge, only 16% of ACS patients met the guideline. No covariates predicted 
guideline adherence (P all >0.05).
Our data suggest that remarkably few patients are achieving targets for physical activity after 
ACS. Our estimates are substantially lower than those based on self-report (5). Limitations 
of our findings include the moderate sample size, enrollment from a single center, 
accelerometer noncompliance, and inability to assess physical activity during non-wear time. 
These limitations notwithstanding, our data reveal that in a diverse sample, there is an urgent 
need to implement interventions that increase physical activity after ACS. In prior decades, 
ACS survivors were counseled to remain in bed for weeks, and many current patients fear 
exercise after ACS. One approach to counteracting these fears and encouraging physical 
activity has been exercise-based cardiac rehabilitation. Yet, participation in these programs 
remains poor. Objectively monitoring physical activity and providing real-time feedback to 
patients and clinicians may be a disseminable approach for increasing physical activity in 
ACS survivors.
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Figure 1. Percentage of Acute Coronary Syndrome Survivors Meeting Guidelines for Moderate-
to-Vigorous Physical Activity (MVPA) by Weeks Post-Discharge (N = 333)
Participants’ physical activity was categorized as “meeting guidelines” (≥30 minutes of 
moderate-to-vigorous intensity physical activity (MVPA) for ≥66% observed days [i.e., 
approximately ≥5 days/week]), “insufficient” (≥30 minutes of MVPA for 1%–65% observed 
days [i.e., approximately 1–4 days/week]), or “none” (0 days with ≥30 MVPA).
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